profgenkanter.bsky.social
Economist and Associate Professor (University of Southern California, Public Policy) geeking out on biomed technologies, FDA, conflicts of interest, ethics in health care and government
👤 Joined on 28 October 2023
Followers
Following
Total Posts
@profgenkanter.bsky.socialMany patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds.. statnews.com/pharmalot/20... #pharma #FDA #money #conflicts #consumers #patients #medicines #drugs
Show PostThis phenomenon is sometimes referred to as "stealth patient/health advocacy" because of the deep connections btw pharma and patient/consumer advocacy. Whose interests are being represented her? Whose interests are prioritized? #MotivatedBias #COIs
Show PostCongratulations to Robert E. Hall of @stanford.edu and Michael Woodford of @columbiauniversity.bsky.social on winning the @nobelprize.org in Economic Sciences! #econsky www.aeaweb.org/news/nobel-p...
Show PostAnalyzing academic affiliations of 6,000 award-winning researchers in 18 major fields in the natural sciences, engineering, and social sciences from the 1820s to the 2020s, focusing on the 1960s onward, from Richard B. Freeman, Danxia Xie, Hanzhe Zhang, and Hanzhang Zhou www.nber.org/papers/w35875
Show PostWhy does OpenAI’s rogue system sound like it was assembling a dataset to write an undergraduate honors thesis in economics? www.nytimes.com/2026/09/25/t...
Show Post